Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336282 · ClinicalTrials.gov registry record · NA
Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT02336282 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 53 participants.
The verdict
NCT02336282, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
A common and potentially debilitating late effect of childhood cancer treatment is neurocognitive impairment, frequently in the domain of executive dysfunction, which can limit educational attainment, employment, and quality of life. Among the survivors of childhood acute lymphoblastic leukemia (ALL) in the SJLIFE cohort, the frequency of executive function impairment has been shown as high as 58.8%, with moderate to severe impairment as high as 33.5%, and risk for impairment increased with time from diagnosis. Given the potential of pervasive impact of neurocognitive impairment on daily life, interventions directed at reducing neurocognitive dysfunction among childhood cancer survivors with long-term follow-up are needed. This study examines the potential feasibility and efficacy of a novel intervention to improve executive function. Primary Objectives: * To evaluate the feasibility of a home-based intervention using Transcranial Direct Current Stimulation (tDCS) and cognitive training in adult survivors of childhood ALL participating in the SJLIFE protocol at St. Jude Children's Research Hospital (SJCRH). Secondary Objectives: * To estimate the efficacy of a tDCS intervention paired with cognitive training. * To explore the short-term effect of tDCS on measures of executive function among adult survivors of childhood ALL participating in the SJLIFE protocol
Interventions
- DEVICE Sham
- DEVICE transcranial Direct Current Stimulation (tDCS)
- OTHER Cognitive Assessment
- OTHER Brain Games Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2015-01-12 |
| Est. Completion | 2017-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02336282
The ClinicalTrials.gov registry entry for NCT02336282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sham is the first listed.
NCT02336282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02336282 about?
NCT02336282 is a clinical study titled "Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia". A common and potentially debilitating late effect of childhood cancer treatment is neurocognitive impairment, frequently in the domain of executive dysfunction, which can limit educational attainment, employment, and quality of life. Among the survivors of childhood acute lymphoblastic leukemia (ALL...
What is the current status of trial NCT02336282?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2015-01-12. Estimated completion is 2017-07-20.
What interventions are being tested in trial NCT02336282?
The interventions under investigation include: Sham (DEVICE), transcranial Direct Current Stimulation (tDCS) (DEVICE), Cognitive Assessment (OTHER), Brain Games Stimulation (OTHER).
Who is sponsoring clinical trial NCT02336282?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.